This gene encodes a protein that shares sequence similarity with ribosomal protein L3. The protein belongs to the L3P family of ribosomal proteins. Unlike the ubiquitous expression of ribosomal protein genes, this gene has a tissue-specific pattern of expression, with the highest levels of expression in skeletal muscle and heart. It is not currently known whether the encoded protein is a functional ribosomal protein or whether it has evolved a function that is independent of the ribosome.
Pathway
Cap-dependent Translation Initiation; Cytoplasmic Ribosomal Proteins; Disease; Eukaryotic Translation Elongation; Eukaryotic Translation Initiation; Eukaryotic Translation Termination; Formation of a pool of free 4S subunits; GTP hydrolysis and joining of the 6S ribosomal subunit; Gene Expression; Influenza Infection; Influenza Life Cycle.
Custom Antibody Labeling
We offer labeled antibodies using our catalogue antibody products and a broad range of intensely fluorescent dyes and labels including HRP, biotin, ALP, Alexa Fluor® dyes, DyLight® Fluor dyes, R-phycoerythrin (R-PE), at scales from less than 100 μg up to 1 g of IgG antibody. Learn More
Citations
Have you cited DCABH-201397 in a publication? Let us know and earn a reward for your research.
VanRaay, TJ; Connors, TD; et al. A novel ribosomal protein L3-like gene (RPL3L) maps to the autosomal dominant polycystic kidney disease gene region. GENOMICS 37:172-176(1996).
Gupta, V; Warner, JR; et al. Ribosome-omics of the human ribosome. RNA-A PUBLICATION OF THE RNA SOCIETY 20:1004-1013(2014).
Payment methods we support:
Invoice / Purchase Order
Credit card
My Review for Anti-RPL3L monoclonal antibody
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.